Microbot Medical Inc. (MBOT) has a consensus analyst rating of Buy, based on 3 analysts covering the stock. Of those, 2 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for MBOT is $5.50, representing a +126.3% upside from the current price of $2.43. Price targets range from a low of $5.50 to a high of $5.50.
